BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2991939)

  • 1. Metabolism and selectivity of arabinonucleoside in human lymphoid cells.
    Fridland A; Verhoef V
    Proc Soc Exp Biol Med; 1985 Sep; 179(4):456-62. PubMed ID: 2991939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts.
    Verhoef V; Fridland A
    Cancer Res; 1985 Aug; 45(8):3646-50. PubMed ID: 2410098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and selective cytotoxicity of 9-beta-D-arabinofuranosylguanine in human lymphoblasts.
    Shewach DS; Daddona PE; Ashcraft E; Mitchell BS
    Cancer Res; 1985 Mar; 45(3):1008-14. PubMed ID: 3971358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.
    Rodriguez CO; Mitchell BS; Ayres M; Eriksson S; Gandhi V
    Cancer Res; 2002 Jun; 62(11):3100-5. PubMed ID: 12036920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
    Kurtzberg J; Hershfield MS
    Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific cytotoxicity of arabinosylguanine toward cultured T lymphoblasts.
    Ullman B; Martin DW
    J Clin Invest; 1984 Sep; 74(3):951-5. PubMed ID: 6332120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms for T-cell selective cytotoxicity of arabinosylguanine.
    Rodriguez CO; Stellrecht CM; Gandhi V
    Blood; 2003 Sep; 102(5):1842-8. PubMed ID: 12750168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.
    Ramilo-Torno LV; Avramis VI
    Cancer Chemother Pharmacol; 1995; 35(3):191-9. PubMed ID: 7805176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-adenosylhomocysteine hydrolase inactivation and purine toxicity in cultured human T- and B-lymphoblasts.
    Young GJ; Hallam LJ; Jack I; Van Der Weyden MB
    J Lab Clin Med; 1984 Jul; 104(1):86-95. PubMed ID: 6330251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2'-deoxyguanosine toxicity for B and mature T lymphoid cell lines is mediated by guanine ribonucleotide accumulation.
    Sidi Y; Mitchell BS
    J Clin Invest; 1984 Nov; 74(5):1640-8. PubMed ID: 6334099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential metabolism of 9-beta-D-arabinofuranosylguanine in human leukemic cells.
    Shewach DS; Mitchell BS
    Cancer Res; 1989 Dec; 49(23):6498-502. PubMed ID: 2819707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arabinosylguanine-induced apoptosis of T-lymphoblastic cells: incorporation into DNA is a necessary step.
    Rodriguez CO; Gandhi V
    Cancer Res; 1999 Oct; 59(19):4937-43. PubMed ID: 10519407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of arabinosyl nucleotides in K562 human leukemia cells.
    Gandhi V; Plunkett W
    Biochem Pharmacol; 1989 Oct; 38(20):3551-8. PubMed ID: 2479383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and actions of 2-chloro-9-(2-deoxy-2-fluoro-beta-D- arabinofuranosyl)-adenine in human lymphoblastoid cells.
    Xie C; Plunkett W
    Cancer Res; 1995 Jul; 55(13):2847-52. PubMed ID: 7540950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K; Nayak R; Grant S
    Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nelarabine-resistant T-lymphoblastic leukemia CCRF-CEM variant cell line is cross-resistant to the purine nucleoside phosphorylase inhibitor forodesine.
    Yamauchi T; Uzui K; Nishi R; Tasaki T; Ueda T
    Anticancer Res; 2014 Sep; 34(9):4885-92. PubMed ID: 25202070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced drug incorporation into DNA and antiapoptosis as the crucial mechanisms of resistance in a novel nelarabine-resistant cell line.
    Yamauchi T; Uzui K; Nishi R; Shigemi H; Ueda T
    BMC Cancer; 2014 Jul; 14():547. PubMed ID: 25070259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purine nucleoside kinases in human T- and B-lymphoblasts.
    Yamada Y; Goto H; Ogasawara N
    Biochim Biophys Acta; 1983 Nov; 761(1):34-40. PubMed ID: 6315069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential composition of cytosol 5'-nucleotidases between T and B lymphoblasts.
    Iizasa T; Takeuchi F; Honda Z; Nishida Y; Kamatani N; Miyamoto T
    Biochim Biophys Acta; 1986 Jun; 882(2):228-33. PubMed ID: 3011114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new high-performance liquid chromatography method determines low production of 9-beta-D-arabinofuranosylguanine triphosphate, an active metabolite of nelarabine, in adult T-cell leukemia cells.
    Yamauchi T; Nishi R; Kitazumi K; Nakano T; Ueda T
    Oncol Rep; 2010 Feb; 23(2):499-504. PubMed ID: 20043113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.